Table 1.
Variable | 4w | 8w | 16w | |||
---|---|---|---|---|---|---|
Control (n = 5) |
VDD (n = 5) |
Control (n = 5) |
VDD (n = 5) |
Control (n = 5) |
VDD (n = 5) |
|
TG (mmol/l) | 2.57 ± 0.19 | 3.30 ± 0.27*** | 2.60 ± 0.09 | 2.91 ± 0.21 | 2.68 ± 0.16 | 3.10 ± 0.14* |
HDL-C (mmol/l) | 7.91 ± 0.43 | 6.59 ± 1.33 | 6.54 ± 0.75 | 4.9 ± 0.52* | 5.9 ± 0.44 | 4.92 ± 0.51 |
INS (mU/L) | 6.74 ± 0.34 | 8.08 ± 0.59** | 6.89 ± 0.76 | 6.99 ± 0.15 | 6.26 ± 0.53 | 7.12 ± 0.46 |
FBG (mmol/l) | 12.37 ± 0.85 | 11.38 ± 2.72 | 11.38 ± 0.45 | 15.16 ± 3.67 | 7.96 ± 2.31 | 15.69 ± 2.01*** |
HOMA-IR | 3.7 ± 0.23 | 4.11 ± 1.18 | 3.49 ± 0.46 | 4.72 ± 1.18 | 2.20 ± 0.55 | 4.98 ± 0.79*** |
HOMA-S | 0.27 ± 0.02 | 0.26 ± 0.06 | 0.29 ± 0.04 | 0.22 ± 0.06 | 0.48 ± 0.11 | 0.20 ± 0.03*** |
HOMA-β | 15.33 ± 1.91 | 22.19 ± 6.98 | 17.48 ± 1.72 | 13.15 ± 4.69 | 33.42 ± 13.43 | 11.92 ± 1.99*** |
calcium (mmol/l) | 2.53 ± 0.16 | 2.54 ± 0.18 | 2.41 ± 0.17 | 2.45 ± 0.21 | 2.47 ± 0.13 | 2.44 ± 0.16 |
FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-S, insulin sensitivity; HOMA-β, β-cell function; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; n. Normally distributed data are presented as means ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group.